Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 6,620.00
-340.00 (-4.89%)
At close: Apr 2, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 47.74 billion as of April 2, 2026. Its market cap has increased by 17.64% in one year.
Market Cap
47.74B
Enterprise Value
33.21B
Revenue
35.24B
Ranking
n/a
PE Ratio
7.21
Stock Price
6,620.00
Market Cap Chart
Since January 26, 2021, Wonbiogen's market cap has increased from 47.59B to 47.74B, an increase of 0.31%. That is a compound annual growth rate of 0.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 47.74B | 0.75% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG MedTech | 232.85B |
| OSTEONIC | 133.81B |
| Sewoon Medical | 113.42B |
| JW Shinyak | 110.57B |
| SCL Science | 74.84B |
| KM Corporation | 47.86B |
| MEDYSSEY Co.,Ltd | 39.13B |
| DOBU Inc. | 34.09B |